[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nrx Pharmaceuticals Inc (NRXP)

Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nrx Pharmaceuticals Inc 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 USA

www.nrxpharma.com Employees: 29 P: 484-254-6134

Sector:

Medical

Description:

NRX Pharmaceuticals Inc. is a patient-focused, clinical stage pharmaceutical company. It creates therapies to treat diseases where no medicines currently exist. NRX Pharmaceuticals Inc., formerly known as Big Rock Partners Acquisition Corp., is based in RADNOR, Pa.

Key Statistics

Overview:

Market Capitalization, $K 143,829
Enterprise Value, $K 136,029
Shares Outstanding, K 36,229
Float, K 33,910
% Float 93.60%
Short Interest, K 4,976
Short Float 13.73%
Days to Cover 3.02
Short Volume Ratio 0.41
% of Insider Shareholders 6.40%
% of Institutional Shareholders 4.27%

Financials:

Annual Sales, $ 1,230 K
Annual Net Income, $ -28,620 K
Last Quarter Sales, $ 1,070 K
Last Quarter Net Income, $ -1,430 K
EBIT, $ -16,990 K
EBITDA, $ -16,850 K

Growth:

1-Year Return 22.91%
3-Year Return -20.92%
5-Year Return -97.17%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 05/15/26
Next Earnings Date 08/17/26
Earnings Per Share ttm -1.01
EPS Growth vs. Prev Qtr -121.05%
EPS Growth vs. Prev Year 88.24%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 04/02/24

NRXP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -202.92%
Profit Margin % -2,326.83%
Debt/Equity 0.00
Price/Sales 117.71
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.42
Interest Coverage -41.72
60-Month Beta 2.14
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.